ByMedullaxFebruary 7, 2026 AI Method Links CXR Evidence to CT Quantification for ILD Diagnosis Clinical AI & Diagnostics
ByMedullaxFebruary 7, 2026 MHRA Highlights Rare NAION Risk with Semaglutide (Wegovy, Ozempic, Rybelsus) Government & Funding Research & Evidence
ByMedullaxFebruary 7, 2026 AI Model Predicts Intracranial Aneurysm Hemodynamics in Real Time Clinical AI & Diagnostics
ByMedullaxFebruary 5, 2026 AI in Prior Authorisation: Emerging Concerns for Patient Access Clinical AI & Diagnostics Regulation & Safety
ByMedullaxFebruary 2, 2026 Speech-based digital biomarkers: A new frontier for cognitive impairment assessment Clinical AI & Diagnostics
ByMedullaxFebruary 2, 2026 Applying Aviation Safety Principles to Clinical AI Collaboration Clinical AI & Diagnostics Regulation & Safety
ByMedullaxFebruary 2, 2026 GLP-1 Medicines: New Government Guidance for Clinicians on Weight Loss and Diabetes Government & Funding
ByMedullaxFebruary 1, 2026 New initiative aims to boost rare cancer patient access to breakthrough trials Government & Funding
ByMedullaxJanuary 30, 2026 Mitigating Risks: Ensuring Patient Safety in Psychiatric Virtual Environments Clinical AI & Diagnostics Regulation & Safety
ByMedullaxJanuary 30, 2026 Pancreatitis Risk: GLP-1 Agonist Warnings Strengthened Following Fatal Cases Government & Funding Research & Evidence
